India's First Covid-19 Antidote Ready For Phase-3 Trials October 14, 2022 According to an official UoH spokesperson, VINCOV-19 is now ready for market authorisation and for simultaneous phase 3 clinical trials Share Get link Facebook X Pinterest Email Other Apps Labels Health Share Get link Facebook X Pinterest Email Other Apps Comments
Comments
Post a Comment